Just Published

JCP
Paliperidone Palmitate 351 mg as Alternative Maintenance Doses in Patients With Schizophrenia or Schizoaffective Disorder
Original Research ▶ Video

Paliperidone Palmitate 351 mg as Alternative Maintenance Doses in Patients With Schizophrenia or Schizoaffective Disorder

September 16, 2026

This analysis suggests that maintenance doses of paliperidone palmitate 351 mg at different dosing intervals may offer additional treatment options for clinical use.
, , , et al
Who Gets Excluded from Psychedelic Trials in GAD, and Why
news

Who Gets Excluded from Psychedelic Trials in GAD, and Why

September 16, 2026

Psychedelic trials in generalized anxiety disorder exclude participants based on cardiac risk from 5-HT2B agonism, personal and family psychiatric history, and psychotropic washout requirements.
Measurement-Based Care in Generalized Anxiety Disorder
news

Measurement-Based Care in Generalized Anxiety Disorder

September 16, 2026

Measurement-based care in GAD rests on validated tools and guideline timepoints, but no trial has yet isolated the effect of measurement itself.
Switching From Oral Atypical Antipsychotics to Xanomeline-Trospium in Schizophrenia

Switching From Oral Atypical Antipsychotics to Xanomeline-Trospium in Schizophrenia

September 15, 2026

A Clinical Pearl on switching patients from oral atypical antipsychotics to xanomeline-trospium: 2- vs 4-week taper data and panel guidance.
PCC
The Aftermath of Risking Life and Limb
Rounds in the General Hospital

The Aftermath of Risking Life and Limb

September 15, 2026

Traumatic injuries (often the result of impulsive and thoughtless behaviors) are potent drivers of disability, disfigurement, PTSD, TBIs, mortality, and high health care costs.
, , , et al
JCP
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress
Original Research

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress

September 14, 2026

Adjunctive lumateperone 42 mg significantly improved depression and anxiety symptoms in patients with MDD with inadequate antidepressant response and anxious distress
, , , et al

Explore
By Topic

View all topics
Addiction Anxiety Bipolar Disorder Depression (MDD) Movement Disorders Neurology Obsessive-Compulsive and Related Disorders Psychedelics Psychopharmacology Schizophrenia/Schizoaffective Disorders Tardive Dyskinesia

Recent Features

Neural network illustration exploring psychedelic therapy mechanisms
Portrait of Dr. David T. Liebers discussing metabolism in psychiatry
Promotional graphic shows Biostats Made Simple by Dr. Andrade, promoting mastering statistics for clinical decisions.
The Journal of Clinical Psychiatry logo with person reading research publication

Original Research

JCP
Long-Acting Injectable Antipsychotics and Clozapine in Coordinated Specialty Care: Data From EPINET
Original Research

Long-Acting Injectable Antipsychotics and Clozapine in Coordinated Specialty Care: Data From EPINET

September 14, 2026

Data from the EPINET project reveal wide variation in the prescription of LAIs and clozapine across first-episode specialty care clinics.
, , , et al
PCC
Vision Outcomes in Children With Mental, Emotional, Developmental, or Behavioral Problems
Original Research

Vision Outcomes in Children With Mental, Emotional, Developmental, or Behavioral Problems

September 10, 2026

This study evaluated whether vision care utilization, screening/referral steps, and vision-related outcomes differ by mental, emotional, developmental, or behavioral disorder status in US children.
, , , et al
JCP
Utilizing a Smartphone Application for Perinatal Depression Screening and Care Linkages
Original Research

Utilizing a Smartphone Application for Perinatal Depression Screening and Care Linkages

September 9, 2026

The prevalence of probable perinatal depression was comparable to that in US women, demonstrating the app’s ability to identify perinatal depression.
, , , et al

The Journal of Clinical Psychiatry

The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals. Now featuring The JCP Podcast: conversations with experts exploring the research shaping clinical care.  

EXPLORE JCP
JCP
Voice of the Patient
Commentary

Voice of the Patient

September 9, 2026

Discusses a recent study by Bayrampour et al of the use of speech features for prediction of MDD and GAD during pregnancy.
JCP
Using Speech to Predict MDD and GAD During Pregnancy
Original Research

Using Speech to Predict MDD and GAD During Pregnancy

September 9, 2026

Influential speech features for prediction of MDD and GAD during pregnancy were similar to those in the general population.
, , , et al

Explore Special Sections from JCP

Focus on Childhood and Adolescent Mental Health Early Career Psychiatrists Focus on Geriatric Psychiatry Focus on Psychosis Focus on Psychotherapy Focus on Suicide Focus on Women’s Mental Health

The Primary Care Companion for CNS Disorders

The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.

View PCC Articles
PCC
Lorazepam in Chronic Catatonia Reversal
Case Report

Lorazepam in Chronic Catatonia Reversal

September 10, 2026

This report describes chronic organic catatonia following cerebral malaria in a 17-year-old male, who experienced a marked response to lorazepam.
, ,
PCC
When Medical Mistakes Leave Lasting Damage
Rounds in the General Hospital

When Medical Mistakes Leave Lasting Damage

September 8, 2026

After a medical error, tone and nonverbal cues matter; clinicians should give patients ample time to ask questions.
, , , et al

ASCP - American Society of Clinical Psychopharmacology logo

Read articles from ASCP Corner

ASCP Corner

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe